Cargando…
Overview of HCV Life Cycle with a Special Focus on Current and Possible Future Antiviral Targets
Hepatitis C infection is the leading cause of liver diseases worldwide and a major health concern that affects an estimated 3% of the global population. Novel therapies available since 2014 and 2017 are very efficient and the WHO considers HCV eradication possible by the year 2030. These treatments...
Autores principales: | Alazard-Dany, Nathalie, Denolly, Solène, Boson, Bertrand, Cosset, François-Loïc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356578/ https://www.ncbi.nlm.nih.gov/pubmed/30621318 http://dx.doi.org/10.3390/v11010030 |
Ejemplares similares
-
HCV Interplay with Lipoproteins: Inside or Outside the Cells?
por: Cosset, François-Loïc, et al.
Publicado: (2020) -
The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle types
por: Denolly, Solène, et al.
Publicado: (2017) -
Nup98 Is Subverted from Annulate Lamellae by Hepatitis C Virus Core Protein to Foster Viral Assembly
por: Boson, Bertrand, et al.
Publicado: (2022) -
The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles
por: Boson, Bertrand, et al.
Publicado: (2020) -
Low-density hepatitis C virus infectious particles are protected from oxidation by secreted cellular proteins
por: Granier, Christelle, et al.
Publicado: (2023)